Zobrazeno 1 - 10
of 1 459
pro vyhledávání: '"Koichi, Hirata"'
Autor:
Keisuke Suzuki, Shiho Suzuki, Hiroaki Fujita, Hirotaka Sakuramoto, Mukuto Shioda, Koichi Hirata
Publikováno v:
Neuropsychopharmacology Reports, Vol 44, Iss 2, Pp 482-484 (2024)
Abstract Recently, calcitonin gene‐related peptide (CGRP) monoclonal antibodies (mAbs) have become available as a prophylactic treatment for migraine and have shown high efficacy and safety in clinical practice. CGRP mAbs have been reported to be e
Externí odkaz:
https://doaj.org/article/a98f1b257c6d40e4abf51f59df39d7d0
Autor:
Takao Takeshima, Koichi Hirata, Hisaka Igarashi, Fumihiko Sakai, Hiromi Sano, Hiroyuki Kondo, Yoshiyuki Shibasaki, Nobuyuki Koga
Publikováno v:
BMC Neurology, Vol 24, Iss 1, Pp 1-12 (2024)
Abstract Background Surveys using questionnaires to collect epidemiologic data may be subject to misclassification. Here, we analyzed a headache questionnaire to evaluate which questions led to a classification other than migraine. Methods Anonymized
Externí odkaz:
https://doaj.org/article/f1bbacc457f54f98803ae1e77a452163
Autor:
Tsubasa Takizawa, Keiko Ihara, Narumi Watanabe, Ryo Takemura, Nobuyuki Takahashi, Naoki Miyazaki, Mamoru Shibata, Keisuke Suzuki, Noboru Imai, Norihiro Suzuki, Koichi Hirata, Takao Takeshima, Jin Nakahara
Publikováno v:
The Journal of Headache and Pain, Vol 25, Iss 1, Pp 1-10 (2024)
Abstract Background Anti-calcitonin gene-related peptide monoclonal antibodies (CGRPmAbs) have greatly changed migraine treatment options. In Japan, although CGRPmAb guidelines (≥ 4 monthly migraine days (MMDs) and ≥ 1 previous preventive failure
Externí odkaz:
https://doaj.org/article/01b79095541b444eb414caea23415c35
Autor:
Hisaka Igarashi, Mika Komori, Kaname Ueda, Anthony J. Zagar, Dena H. Jaffe, Yasuhiko Matsumori, Takao Takeshima, Koichi Hirata
Publikováno v:
Brain and Behavior, Vol 14, Iss 7, Pp n/a-n/a (2024)
Abstract Introduction Migraine‐related stigma (MiRS) and social burden is increasingly recognized. We assessed perspectives and attitudes toward migraine in people with and without migraine in Japan. Methods OVERCOME (Japan) was a cross‐sectional
Externí odkaz:
https://doaj.org/article/f6c9cd6714934419a5839cae39f7fbd7
Autor:
Etsuko Awaki, Takao Takeshima, Yasuhiko Matsumori, Koichi Hirata, Naoki Miyazaki, Ryo Takemura, Satoshi Osaga, Yoshinori Tanizawa, Mika Komori
Publikováno v:
Neurology and Therapy, Vol 13, Iss 1, Pp 165-182 (2024)
Abstract Introduction The impacts of migraine on daily life, including daily activities and fundamental health indicators (sleep and mental health), have not been described in detail for people with migraine in Japan. Methods The cross-sectional Obse
Externí odkaz:
https://doaj.org/article/12785cdb740641219cb921d5469aa267
Autor:
Koichi Hirata, Mika Komori, Kaname Ueda, Anthony J. Zagar, Yongin Kim, Dena H. Jaffe, Yasuhiko Matsumori, Takao Takeshima
Publikováno v:
Drugs - Real World Outcomes, Vol 10, Iss 3, Pp 415-428 (2023)
Abstract Background Knowledge of patient outcomes and treatment effectiveness associated with acute migraine treatments in Japan is lacking. Objective To describe patient-reported outcomes (PROs) and treatment effectiveness in three acute treatment g
Externí odkaz:
https://doaj.org/article/90a0414869bb48debc6a4158d4d97ec8
Autor:
Keisuke Suzuki, Shiho Suzuki, Yasuo Haruyama, Kei Funakoshi, Hiroaki Fujita, Hirotaka Sakuramoto, Mai Hamaguchi, Gen Kobashi, Koichi Hirata
Publikováno v:
Frontiers in Neurology, Vol 15 (2024)
ObjectiveSleep disturbances are common in migraine patients and affect quality of life. Central sensitization (CS) is likely to play a role in the increased severity and chronicity of migraine. We hypothesized that the number of comorbid sleep proble
Externí odkaz:
https://doaj.org/article/1f4964b1bfe146fb971eb2fd67207eb7
Autor:
Keisuke Suzuki, Shiho Suzuki, Tomohiko Shiina, Yasuo Haruyama, Saro Kobayashi, Mukuto Shioda, Koichi Hirata
Publikováno v:
Heliyon, Vol 10, Iss 4, Pp e26568- (2024)
Background: Real-world evidence of erenumab effectiveness in migraine patients in Asia with various comorbidities and multiple previous medication failures is still limited. Methods: A 6-month single-center cohort study of 45 patients with episodic o
Externí odkaz:
https://doaj.org/article/c83c6edad29e4056bbfe231df1ee3371
Publikováno v:
Frontiers in Neurology, Vol 14 (2023)
PurposeThe study aimed to validate and compare coding algorithms for identifying people with migraine within the Japanese claims database.MethodsThis study used the administrative claim database provided by DeSC Healthcare, Inc., that was linked to t
Externí odkaz:
https://doaj.org/article/1473769a9a814a9a8b3e7d68a081374e
Publikováno v:
Cephalalgia Reports, Vol 6 (2023)
Objective: To determine the rate of wearing-off effects of monthly and quarterly dosing of fremanezumab based on real-world data. Methods: We conducted an observational, single-center cohort study including 101 high-frequency episodic migraine or chr
Externí odkaz:
https://doaj.org/article/cc5feba5448b4d7689ee32c75ca29f31